Cialis and sudden hearing loss: what Australian men need to know

Cialis, the brand name for tadalafil, is one of the most recognised treatments for erectile dysfunction across the world. In Australia, it sits alongside sildenafil (Viagra) and vardenafil as a prescription-only medicine, and millions of scripts are written each year through the Pharmaceutical Benefits Scheme and private pharmacy channels. Yet every medication carries risks, and over the past two decades a specific safety signal has emerged that concerns both regulators and patients: a possible link between PDE5 inhibitors and sudden hearing loss.

This article unpacks what the evidence actually says, how Australian authorities have responded, and what practical steps men in Sydney, Melbourne, Brisbane and beyond can take if they experience ear-related symptoms while using tadalafil. The goal is to cut through the noise, separate genuine warnings from marketing spin, and help you make an informed choice about your health.

The FDA safety communication explained

In 2007, the United States Food and Drug Administration updated the labelling for all PDE5 inhibitors, including tadalafil, sildenafil, and vardenafil, to include warnings about sudden hearing loss. The decision followed dozens of post-marketing reports describing cases of sudden sensorineural hearing loss (SSHL), sometimes accompanied by tinnitus, dizziness, or vertigo. Many of these reports involved men in their 50s and 60s, though cases have been recorded across a wider age range.

The FDA's communication did not claim that tadalafil definitively causes hearing damage. Instead, it acknowledged a plausible signal and instructed manufacturers to add the warning to patient information leaflets. Health authorities elsewhere, including the Therapeutic Goods Administration (TGA) in Australia, have monitored the issue closely and maintain their own adverse-event reporting systems through the Advisory Committee on the Safety of Medicines.

How often the problem actually occurs

Putting the risk into perspective matters. The number of confirmed SSHL cases linked to tadalafil remains very small relative to the millions of men who use the drug every year. Spontaneous reporting databases, such as the FDA Adverse Event Reporting System and Australia's Database of Adverse Event Notifications, capture only suspected associations rather than proven causation. Many of the reports involve patients taking other medications, dealing with underlying cardiovascular disease, or both.

Research published in peer-reviewed journals has produced mixed results. Some case-control studies have suggested a modest increase in risk, while large cohort analyses have not consistently replicated the finding. The honest answer is that the evidence is inconclusive but worth respecting. The rarity of the event does not make it irrelevant, particularly because hearing loss can become permanent without rapid treatment.

Recognising the warning signs

Sudden sensorineural hearing loss typically develops over a few hours or upon waking. It usually affects one ear, though both can be involved. The drop in hearing may be mild or severe, and it is often described as a feeling of fullness, muffling, or blockage. Tinnitus, a ringing or buzzing sound, accompanies the hearing loss in roughly half of cases, and some patients also experience dizziness or imbalance.

These symptoms require urgent medical attention. Australian guidelines recommend seeing a GP or presenting to an emergency department within 24 to 48 hours, because treatment with corticosteroids is most effective when started early. If you are taking tadalafil and notice any of these changes, the medication should be stopped immediately and the event reported to your prescriber.

Who may face higher risk

Certain groups appear more vulnerable to SSHL, regardless of medication use. Men over 60, those with a history of cardiovascular disease, smokers, and individuals with poorly controlled diabetes all show higher baseline rates. The combination of tadalafil with other ototoxic drugs, including some antibiotics and chemotherapy agents, may also amplify the danger, though specific interactions vary.

Australian men who buy tadalafil through legitimate pharmacy channels after a consultation with a registered AHPRA practitioner are generally safer than those who self-source from unverified online sellers. A proper medical review screens for contraindications such as nitrate use, recent stroke, or uncontrolled blood pressure, all of which influence both cardiovascular and auditory risk.

The TGA position and Australian prescribing rules

In Australia, tadalafil is classified as an S4 prescription-only medicine. The TGA requires that all products dispensed within the country carry approved Consumer Medicine Information leaflets, which include the standard PDE5 inhibitor warnings about hearing loss. Doctors in Adelaide, Perth, and regional centres follow the same Therapeutic Guidelines as their city counterparts, and any adverse event can be lodged through the TGA's online reporting portal.

The Pharmaceutical Benefits Scheme does not subsidise tadalafil for erectile dysfunction, so most men pay privately for the medication. This places additional responsibility on the patient to seek proper medical advice rather than relying on internet-only sources. When purchasing from a registered Australian pharmacy, you receive a product that has been stored correctly, batch-tracked, and dispensed under professional supervision.

Using daily tadalafil safely

For men prescribed the 5mg daily dose, the safety profile is well established in clinical trials spanning several years. A practical overview of tadalafil for daily use benefits and risks can help frame the conversation with your GP, particularly if you are weighing continuous therapy against on-demand dosing.

Daily users should maintain a regular review schedule, typically every six to twelve months, to check blood pressure, lipid levels, and any emerging symptoms. Avoid combining tadalafil with grapefruit juice, which raises plasma concentrations, and never use it alongside nitrate medications prescribed for angina. If a new hearing symptom appears, document the timing and seek help the same day.

What to do if symptoms appear

Stop taking tadalafil at the first sign of ear fullness, ringing, or reduced hearing. Contact your GP, visit an urgent care clinic, or go directly to a hospital emergency department. In major centres such as Sydney and Melbourne, ENT specialists are on call through public hospitals, and private referrals can be arranged quickly. The faster you act, the better your chances of preserving hearing.

Some men who experience SSHL while on tadalafil explore alternative sources for ongoing treatment once they have recovered. A few look at international pharmacy options such as overseas suppliers when local stock is limited, though importing prescription medicines into Australia without a valid Australian script remains a grey area under TGA personal importation rules. Discuss any planned change in medication with your doctor before switching suppliers or formulations.

Take control of your health by booking a medication review with your GP before continuing or starting tadalafil, and report any unusual symptoms to the TGA on the same day they appear.